ABCB
Ameris Bancorp
ABCB's outlook is improving, though it still trails on the overall score.
BAC
Bank of America Corporation
BAC has the edge over ABCB overall, supported by stronger fundamentals and stronger valuation.
ABCB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
ABCB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like ABCB.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
ABCB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.8x | $50.20 | -39% |
| Fair | 11x | $65.46 | -21% |
| Forward | 12x | $82.50 | — |
| Expensive | 14x | $79.44 | -3.7% |
| Current | 14x | $82.50 | — |
Historical ranges are pointers, not guarantees.
ABCB's PE is in its expensive range at 14x. If earnings grow as analysts expect, today's price would be 12x next year's earnings, in its fair range.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over ABCB in the historical PE scenario, which offers more potential upside but is not a forecast.
ABCB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect ABCB's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over ABCB on the outlook, with more favorable revenue expectations.
ABCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.84 | +20% |
| Q3 2026 | $5.72 | -0.7% |
| Q2 2026 | $5.53 | -2.3% |
| Q1 2026 | $6.36 | +18% |
| Q4 2025 | $6.00 | +16% |
| Q3 2025 | $5.76 | +20% |
| Q2 2025 | $5.66 | +25% |
| Q1 2025 | $5.38 | +31% |
| Q4 2024 | $5.19 | +33% |
ABCB earned $5.72 per share over the past year, about the same as the year before.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
ABCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $321.8M | +2.4% |
| Q2 2026 | $326M | +8.4% |
| Q1 2026 | $314.4M | +10% |
| Q4 2025 | $307.1M | +5.6% |
| Q3 2025 | $314.2M | +11% |
| Q2 2025 | $300.7M | 0% |
| Q1 2025 | $285.9M | +7% |
| Q4 2024 | $290.8M | +11% |
ABCB's revenue has grown year over year for 10 quarters in a row: $322M last quarter, up 2.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 47% | +3.2 points |
| Q2 2026 | 20% | -27 points |
| Q1 2026 | 45% | +5.3 points |
| Q4 2025 | 46% | +2.6 points |
| Q3 2025 | 44% | -0.8 points |
| Q2 2025 | 47% | +5.4 points |
| Q1 2025 | 40% | +3 points |
| Q4 2024 | 43% | +8.9 points |
ABCB has the edge over BAC on profitability, with a higher operating margin.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over ABCB on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
ABCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $213.8M | +113% |
| Q2 2026 | $70.8M | +32% |
| Q1 2026 | $249.4M | +118% |
| Q4 2025 | $101.2M | -20% |
| Q3 2025 | $100.5M | +0.8% |
| Q2 2025 | $53.7M | +$154.1M |
| Q1 2025 | $114.2M | +654% |
| Q4 2024 | $126.1M | -39% |
ABCB has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
ABCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -75.3K shares |
| 1 year | -2.4% | -1.6M shares |
| 3 years | -2.9% | -2M shares |
| 5 years | -3.9% | -2.7M shares |
| Available history | +14% | +8.4M shares |
ABCB has 67M diluted shares, down 2.4% from a year ago, with $144M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $38,000 |
| Q2 2026 | $19.7M |
| Q1 2026 | $83.6M |
| Q4 2025 | $40.8M |
| Q3 2025 | $8.5M |
| Q2 2025 | $12.9M |
| Q1 2025 | $20.7M |
| Q4 2024 | $103,000 |
ABCB spent $144M buying back its own shares over the past year, about three times what it spent the year before.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over ABCB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
ABCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.6x | Healthy |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 1.3x | Healthy |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.4x | Very low |
ABCB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
ABCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.4 | Neutral |
| Stochastic | 39.0 | Neutral |
ABCB's weekly RSI is 47 (neutral) and its Stochastic is 39 (neutral).
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
ABCB PE vs Financial Services Sector
| Metric | ABCB | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 11% above |
| PE % | 90 | 63 | 27 pts above |
ABCB is trading at 14x earnings, a 11% premium to the Financial Services sector's median of 13x.
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over ABCB on valuation relative to its sector.
ABCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $81.5 | 1.3% above |
| 20 week MA | $85.2 | 3.1% below |
| 50 week MA | $82.9 | 0.5% below |
| 100 week MA | $74.2 | 11% above |
| 200 week MA | $60.9 | 35% above |
ABCB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
ABCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.7 | $37.5 | -12% |
| 2021 | $37.5 | $49.2 | +31% |
| 2022 | $49.2 | $47.9 | -2.7% |
| 2023 | $47.9 | $53.1 | +11% |
| 2024 | $53.1 | $63.1 | +19% |
| 2025 | $63.1 | $76.0 | +21% |
| 2026 YTD | $76.0 | $82.5 | +8.6% |
ABCB has the edge over BAC on returns for 2026, with the stronger performance.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.